Huber-Keener K - Search Results

1

Patient and provider factors associated with the noninitiation of tamoxifen for young women at high-risk for the development of breast cancer.

Kandagatla P, Rizk NN, Dokic D, Kochkodan J, Estevez S, Yanik M, Goranta S, Huber-Keener K, Jeruss JS. Kandagatla P, et al. Among authors: huber keener k. Breast J. 2020 Mar;26(3):464-468. doi: 10.1111/tbj.13528. Epub 2019 Sep 20. Breast J. 2020. PMID: 31538708 Free PMC article.

2

Management of Breast Cancer Survivors by Gynecologists.

Huber-Keener KJ. Huber-Keener KJ. Clin Obstet Gynecol. 2022 Sep 1;65(3):494-509. doi: 10.1097/GRF.0000000000000727. Epub 2022 Jun 16. Clin Obstet Gynecol. 2022. PMID: 35708967

3

Foreword: Management of Breast Disorders.

Huber-Keener KJ. Huber-Keener KJ. Clin Obstet Gynecol. 2022 Sep 1;65(3):427-429. doi: 10.1097/GRF.0000000000000728. Epub 2022 Jun 15. Clin Obstet Gynecol. 2022. PMID: 35703227 No abstract available.

4

Cancer genetics and breast cancer.

Huber-Keener KJ. Huber-Keener KJ. Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:3-11. doi: 10.1016/j.bpobgyn.2022.01.007. Epub 2022 Jan 31. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35272929 Review.

5

Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.

Zhang L, Ren X, Cheng Y, Huber-Keener K, Liu X, Zhang Y, Yuan YS, Yang JW, Liu CG, Yang JM. Zhang L, et al. Biochem Pharmacol. 2013 Sep 15;86(6):726-33. doi: 10.1016/j.bcp.2013.06.032. Epub 2013 Jul 12. Biochem Pharmacol. 2013. PMID: 23856293

6

Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data.

Huber-Keener KJ, Liu X, Wang Z, Wang Y, Freeman W, Wu S, Planas-Silva MD, Ren X, Cheng Y, Zhang Y, Vrana K, Liu CG, Yang JM, Wu R. Huber-Keener KJ, et al. PLoS One. 2012;7(7):e41333. doi: 10.1371/journal.pone.0041333. Epub 2012 Jul 23. PLoS One. 2012. PMID: 22844461 Free PMC article.

7

When Should Prophylactic Oophorectomy Be Recommended at the Time of Elective Hysterectomy?

Huber-Keener KJ, Pearlman MD. Huber-Keener KJ, et al. Clin Obstet Gynecol. 2020 Jun;63(2):337-348. doi: 10.1097/GRF.0000000000000521. Clin Obstet Gynecol. 2020. PMID: 31876638

8

Health Disparities in Uterine Cancer: Report From the Uterine Cancer Evidence Review Conference.

Whetstone S, Burke W, Sheth SS, Brooks R, Cavens A, Huber-Keener K, Scott DM, Worly B, Chelmow D. Whetstone S, et al. Among authors: huber keener k. Obstet Gynecol. 2022 Apr 1;139(4):645-659. doi: 10.1097/AOG.0000000000004710. Epub 2022 Mar 10. Obstet Gynecol. 2022. PMID: 35272301 Free PMC article. Review.

9

Executive Summary of the Uterine Cancer Evidence Review Conference.

Chelmow D, Brooks R, Cavens A, Huber-Keener K, Scott DM, Sheth SS, Whetstone S, Worly B, Burke W. Chelmow D, et al. Among authors: huber keener k. Obstet Gynecol. 2022 Apr 1;139(4):626-643. doi: 10.1097/AOG.0000000000004711. Epub 2022 Mar 10. Obstet Gynecol. 2022. PMID: 35272316 Free PMC article. Review.

10

Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression.

Zhang Y, Cheng Y, Zhang L, Ren X, Huber-Keener KJ, Lee S, Yun J, Wang HG, Yang JM. Zhang Y, et al. Biochem Biophys Res Commun. 2011 Oct 14;414(1):129-34. doi: 10.1016/j.bbrc.2011.09.038. Epub 2011 Sep 16. Biochem Biophys Res Commun. 2011. PMID: 21945617 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page